Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study - Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037605

Enrollment

200

Registered

2019-08-06

Start date

2019-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

partial atrial fibrillation after cardiac surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: atrial fibrillation after cardiac surgery Patients from whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients from whom informed consent was not obtained Hemodialysis Car<15 valve replacement surgery Doctor's decision not to register to this regimen

Design outcomes

Primary

Measure	Time frame
Bleeding event Thromboembolic event	—

Secondary

Measure	Time frame
1) Hb, Ht, BUN, Cr, eGFR, AST, ALT 2) PT-INR, APTT 3) uric blood 4) Blood loss from drain, blood transfusion	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Nihon University School of Medicine Department of Cardiovascular Surgery

asezai.med@gmail.com03-3972-8111

Outcome results